Cargando…

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors

Tacrine was the first drug to be approved for Alzheimer’s disease (AD) treatment, acting as a cholinesterase inhibitor. The neuropathological hallmarks of AD are amyloid-rich senile plaques, neurofibrillary tangles, and neuronal degeneration. The portfolio of currently approved drugs for AD includes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svobodova, Barbora, Mezeiova, Eva, Hepnarova, Vendula, Hrabinova, Martina, Muckova, Lubica, Kobrlova, Tereza, Jun, Daniel, Soukup, Ondrej, Jimeno, María Luisa, Marco-Contelles, José, Korabecny, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723352/ https://www.ncbi.nlm.nih.gov/pubmed/31430943 http://dx.doi.org/10.3390/biom9080379

Ejemplares similares

Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
por: Spilovska, Katarina, et al.
Publicado: (2017)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)

A-agents, misleadingly known as “Novichoks”: a narrative review
por: Opravil, Jakub, et al.
Publicado: (2023)

Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
por: Janockova, Jana, et al.
Publicado: (2018)

Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease
por: Svobodova, Barbora, et al.
Publicado: (2023)

Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D(2) 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole
por: Juza, Radomir, et al.
Publicado: (2021)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Development of 2-Methoxyhuprine as Novel Lead for Alzheimer’s Disease Therapy
por: Mezeiova, Eva, et al.
Publicado: (2017)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
por: Korabecny, Jan, et al.
Publicado: (2015)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings
por: Kuca, Kamil, et al.
Publicado: (2018)

In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
por: Janockova, Jana, et al.
Publicado: (2019)

Neuroactive Multifunctional Tacrine Congeners with Cholinesterase, Anti-Amyloid Aggregation and Neuroprotective Properties
por: Kozurkova, Maria, et al.
Publicado: (2011)

Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists
por: Konecny, Jan, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Chen, Yao, et al.
Publicado: (2017)

Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
por: Remya, Chandran, et al.
Publicado: (2021)

Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
por: Mamun, Abdullah Al, et al.
Publicado: (2021)

Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators
por: Malinak, David, et al.
Publicado: (2020)

Structural, harmonic force field and vibrational studies of cholinesterase inhibitor tacrine used for treatment of Alzheimer's disease
por: Sundius, Tom, et al.
Publicado: (2023)

Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II—Design, Synthesis, and Evaluation
por: Maryška, Michal, et al.
Publicado: (2021)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Zhu, Jie, et al.
Publicado: (2018)

Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer’s disease
por: Yang, Huali, et al.
Publicado: (2023)

7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies
por: Spilovska, Katarina, et al.
Publicado: (2013)

Chemical and Biological Threats, Hazard Potential and Countermeasures
por: Soukup, Ondrej, et al.
Publicado: (2022)

Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
por: Galdeano, Carles, et al.
Publicado: (2018)

Profiling donepezil template into multipotent hybrids with antioxidant properties
por: Mezeiova, Eva, et al.
Publicado: (2018)

Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase
por: Evangelista, Tereza Cristina Santos, et al.
Publicado: (2021)

Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
por: Siatka, Tomáš, et al.
Publicado: (2017)

Therapeutic Potential of Multifunctional Tacrine Analogues
por: Przybyłowska, Maja, et al.
Publicado: (2019)

Evaluation of Cholinesterase Activities During in Vivo Intoxication Using an Electrochemical Sensor Strip – Correlation With Intoxication Symptoms
por: Pohanka, Miroslav, et al.
Publicado: (2009)

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy
por: Rodríguez-Ruiz, Emelina R., et al.
Publicado: (2023)

Is It the Twilight of BACE1 Inhibitors?
por: Hrabinova, Martina, et al.
Publicado: (2021)

QSAR analysis on tacrine-related acetylcholinesterase inhibitors
por: Wong, Kai Y, et al.
Publicado: (2014)

Tacrine-Based Hybrids: Past, Present, and Future
por: Bubley, Anna, et al.
Publicado: (2023)

Formulation, Characterization and Evaluation against SH-SY5Y Cells of New Tacrine and Tacrine-MAP Loaded with Lipid Nanoparticles
por: Silva, Sara, et al.
Publicado: (2020)

Novel Aminoguanidine Hydrazone Analogues: From Potential Antimicrobial Agents to Potent Cholinesterase Inhibitors
por: Krátký, Martin, et al.
Publicado: (2021)

Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells
por: Hudáčová, Monika, et al.
Publicado: (2021)

High-Affinity Anion Binding by Steroidal Squaramide Receptors**
por: Edwards, Sophie J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4707r8ree2q342a3ncti6vavjq